Arkolith/Insider Trading/SRRA/Form 4

Klencke Barbara

Chief Medical OfficerSierra Oncology, Inc. (SRRA) · full profile →Form 4 · filed Jul 1, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
2 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2022Disposed to issuer(D)10K$55.00$550K0
Jul 1, 2022Disposed to issuer(D)5K$55.00$275K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2022Disposed to issuer(D)50K—$00
Jul 1, 2022Disposed to issuer(D)12K—$00
Jul 1, 2022Disposed to issuer(D)2K—$00
Jul 1, 2022Disposed to issuer(D)11K—$00
Jul 1, 2022Disposed to issuer(D)2K—$00
Jul 1, 2022Disposed to issuer(D)5K—$00
Jul 1, 2022Disposed to issuer(D)5K—$00
Jul 1, 2022Disposed to issuer(D)167K—$00
Jul 1, 2022Disposed to issuer(D)49K—$00
Jul 1, 2022Disposed to issuer(D)30K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-040274) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML